Article Details
Retrieved on: 2020-12-22 21:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here